The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Expression of ErbB2 and ErbB3 in resected non-small cell lung cancer (NSCLC) patients (pts).
E. Felip
No relevant relationships to disclose
M. Salcedo
No relevant relationships to disclose
N. Murtra-Garrell
No relevant relationships to disclose
A. Navarro
No relevant relationships to disclose
C. Teixido
No relevant relationships to disclose
J. Hernandez-Losa
No relevant relationships to disclose
S. Cedres
No relevant relationships to disclose
P. Martinez
No relevant relationships to disclose
E. Lopez
No relevant relationships to disclose
M. A. Montero
No relevant relationships to disclose
V. Freixinos
No relevant relationships to disclose
G. Argiles
No relevant relationships to disclose
I. Nuñez
No relevant relationships to disclose
V. Peg
No relevant relationships to disclose
E. Pallisa
No relevant relationships to disclose
M. Canela
No relevant relationships to disclose
J. Tabernero
No relevant relationships to disclose
S. Ramon y Cajal
No relevant relationships to disclose
N. Tallada
No relevant relationships to disclose